Less Invasive Ventricular Enhancement

Enable volume reduction through micro-anchors designed to exclude left ventricular scarred myocardial tissue

The Revivent TC™

Transcatheter Ventricular Enhancement System

Click on image to view larger

Exclude anterior scarred myocardium from viable tissue

Reduce volume, radius, and wall tension

Restore conical morphology

Sternal sparing


A singular focus on the ventricle for less invasive heart failure treatments

Durable Clinical Data that Lasts (1-Year)

Studies have shown that the Revivent TC™ System achieves clinical benefits that result in significant volume reduction and EF improvement.

LVESVI Reduction
LVEDVI Reduction
LVEF Improvement
Exercise Capacity Improvement
QoL Improvement

European clinical data on file​

What doctors have to say about The Revivent TC™ System

Case Study

Less-Invasive Treatment of Adverse Ventricular Remodeling Resulting in Reduction of Secondary Mitral Regurgitation


BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.

Our News

Contact Us

© 2020 BioVentrix. All Rights Reserved. Powered by MedTech Momentum
The Revivent TC™ trademark is a federally registered trademark owned by BioVentrix. Any unauthorized use is expressly prohibited.